GYKI-52466
Gyki-52466 is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target glutamate receptor 1, glutamate receptor 2, glutamate receptor 4, and glutamate receptor 3.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
No data
Commercial
No data
Clinical
No data
Drug
General
| Drug common name | GYKI-52466 |
| INN | talampanel |
| Description | GYKI 52466 is a benzodiazepine. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CC1=NN=C(c2ccc(N)cc2)c2cc3c(cc2C1)OCO3 |
Identifiers
| PDB | — |
| CAS-ID | 102771-26-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL275006 |
| ChEBI ID | 79560 |
| PubChem CID | 3538 |
| DrugBank | — |
| UNII ID | CVS43XG1L5 (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
GRIA1
GRIA1
GRIA2
GRIA2
GRIA4
GRIA4
GRIA3
GRIA3
Organism
Homo sapiens
Gene name
GRIA1
Gene synonyms
GLUH1, GLUR1
NCBI Gene ID
Protein name
glutamate receptor 1
Protein synonyms
AMPA 1, AMPA receptor subunit GluA1, AMPA-selective glutamate receptor 1, GluA1, gluR-1, GluR-A, GluR-K1, Glutamate receptor ionotropic, AMPA 1, glutamate receptor, ionotropic, AMPA 1
Uniprot ID
Mouse ortholog
Gria1 (14799)
glutamate receptor 1 (P23818)
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use